Overexpressing Proprotein-Convertase-Subtilisin-Kexin Type-9 (PCSK9) promotes the lysosomal degradation of LDLR [30], which causes hypercholesterolemia and eventually HCC [31]. Here, PCSK9 is linked to Hypercholesterolemia.